The Role of AI in Basal Insulin Titration in Patients with Type 2 Diabetes Mellitus

Diabetes, affecting millions worldwide, poses a significant challenge to the healthcare system due to the complexity of therapy and difficulty to adequately control the disease. Particularly, patients with Type 2 diabetes often struggle with achieving glycemic control, facing barriers such as limited access to education on the disease state, multiple lines of failed therapies, and lack of timely dose adjustments. A groundbreaking study conducted at Stanford University with results published in the Journal of the American Medical Association explored…